Clinical Trial Update: Peripheral and Coronary Endothelial Dysfunction In Type 2diabetic Patients- Role of Metformin [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating metformin for peripheral and coronary endothelial dysfunction in patients with type 2 diabetes mellitus has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Coronary and Peripheral Endothelial Dysfunction | Phase 3 | Status: TERMINATED